KDR and adrenal cortex carcinoma: Pianovski et al. suggested VEGFR1 and mTOR inhibitors for the treatment of pediatric ACC, demonstrating that almost all the patients overexpressed VEGFR and many patients had activation of the mTOR pathway [137].